Loading...
•
Jun 30
GE HealthCare Q2 2025 Earnings Report
GE HealthCare reported higher net income and EPS driven by solid growth across all business segments in Q2 2025.
Key Takeaways
GE HealthCare delivered strong Q2 2025 results with $5 billion in revenue and increased profitability. Gains were driven by operational execution, lower tax and interest expense, and strength in radiopharma and imaging orders. The company raised its full-year guidance.
Net income rose to $486 million, benefiting from lower tax and interest expense.
Adjusted EPS was $1.06, equal to reported EPS.
All business segments posted year-over-year revenue growth.
Free cash flow turned positive at $7 million after a negative prior year.
GE HealthCare
GE HealthCare
GE HealthCare Revenue by Segment
Revenue by Segment
Imaging Revenue
CapyFin.comAdvanced Visualization Revenue
CapyFin.comPatient Care Solutions Revenue
CapyFin.comPharmaceutical Diagnostics Revenue
CapyFin.comOther Revenue
CapyFin.com Forward Guidance
GE HealthCare raised its full-year 2025 outlook based on healthy demand trends, operational execution, and updated tariff assumptions.
Positive Outlook
- Raised organic revenue growth guidance to approximately 3%
- Increased adjusted EBIT margin guidance to 15.2%–15.4%
- Adjusted EPS guidance lifted to $4.43–$4.63
- Free cash flow guidance raised to at least $1.4 billion
- Strong radiopharma product demand and PET system orders
Challenges Ahead
- Adjusted EBIT margin still below 2024 levels
- Tariff impact expected to reduce EPS by approximately $0.45
- Declining EBIT margins in Imaging and Patient Care Solutions
- Free cash flow remains relatively low in the quarter
- Ongoing restructuring and spin-off costs impacting margins
Revenue & Expenses
Visualization of income flow from segment revenue to net income